These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 27067024)

  • 1. Global genetic diversity of the Plasmodium vivax transmission-blocking vaccine candidate Pvs48/45.
    Vallejo AF; Martinez NL; Tobon A; Alger J; Lacerda MV; Kajava AV; Arévalo-Herrera M; Herrera S
    Malar J; 2016 Apr; 15():202. PubMed ID: 27067024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasmodium vivax gametocyte proteins, Pvs48/45 and Pvs47, induce transmission-reducing antibodies by DNA immunization.
    Tachibana M; Suwanabun N; Kaneko O; Iriko H; Otsuki H; Sattabongkot J; Kaneko A; Herrera S; Torii M; Tsuboi T
    Vaccine; 2015 Apr; 33(16):1901-8. PubMed ID: 25765968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic diversity of transmission-blocking vaccine candidate Pvs48/45 in Plasmodium vivax populations in China.
    Feng H; Gupta B; Wang M; Zheng W; Zheng L; Zhu X; Yang Y; Fang Q; Luo E; Fan Q; Tsuboi T; Cao Y; Cui L
    Parasit Vectors; 2015 Dec; 8():615. PubMed ID: 26627683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant Pvs48/45 antigen expressed in E. coli generates antibodies that block malaria transmission in Anopheles albimanus mosquitoes.
    Arévalo-Herrera M; Vallejo AF; Rubiano K; Solarte Y; Marin C; Castellanos A; Céspedes N; Herrera S
    PLoS One; 2015; 10(3):e0119335. PubMed ID: 25775466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limited genetic diversity in the global Plasmodium vivax Cell traversal protein of Ookinetes and Sporozoites (CelTOS) sequences; implications for PvCelTOS-based vaccine development.
    Mehrizi AA; Torabi F; Zakeri S; Djadid ND
    Infect Genet Evol; 2017 Sep; 53():239-247. PubMed ID: 28600217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restricted genetic heterogeneity of the Plasmodium vivax transmission-blocking vaccine (TBV) candidate Pvs48/45 in a low transmission setting: Implications for the Plasmodium vivax malaria vaccine development.
    Asali S; Raz A; Turki H; Mafakher L; Razmjou E; Solaymani-Mohammadi S
    Infect Genet Evol; 2021 Apr; 89():104710. PubMed ID: 33421653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic diversity and natural selection of transmission-blocking vaccine candidate antigens Pvs25 and Pvs28 in Plasmodium vivax Myanmar isolates.
    Lê HG; Kang JM; Jun H; Lee J; Moe M; Thái TL; Lin K; Myint MK; Yoo WG; Sohn WM; Kim TS; Na BK
    Acta Trop; 2019 Oct; 198():105104. PubMed ID: 31336059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative study on worldwide genetic diversity and population structure analysis of Plasmodium vivax thrombospondin-related adhesive protein (PvTRAP) and its implications for the vivax vaccine design.
    Nazeri S; Mehrizi AA; Djadid ND; Zakeri S
    Infect Genet Evol; 2015 Dec; 36():410-423. PubMed ID: 26477931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limited sequence polymorphisms of four transmission-blocking vaccine candidate antigens in Plasmodium vivax Korean isolates.
    Kang JM; Ju HL; Moon SU; Cho PY; Bahk YY; Sohn WM; Park YK; Cha SH; Kim TS; Na BK
    Malar J; 2013 Apr; 12():144. PubMed ID: 23631662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Worldwide population genetic analysis and natural selection in the Plasmodium vivax Generative Cell Specific 1 (PvGCS1) as a transmission-blocking vaccine candidate.
    Mehrizi AA; Dodangeh F; Zakeri S; Djadid ND
    Infect Genet Evol; 2016 Sep; 43():50-7. PubMed ID: 27180894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequence polymorphisms in Pvs48/45 and Pvs47 gametocyte and gamete surface proteins in Plasmodium vivax isolated in Korea.
    Woo MK; Kim KA; Kim J; Oh JS; Han ET; An SS; Lim CS
    Mem Inst Oswaldo Cruz; 2013 May; 108(3):359-67. PubMed ID: 23778662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic diversity of transmission blocking vaccine candidate (Pvs25 and Pvs28) antigen in Plasmodium vivax clinical isolates from Iran.
    Zakeri S; Razavi S; Djadid ND
    Acta Trop; 2009 Mar; 109(3):176-80. PubMed ID: 18950597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the genetic diversity of domain II of Plasmodium vivax Apical Membrane Antigen 1 (PvAMA-1) and the ensuing strain-specific immune responses in patients from Sri Lanka.
    Dias S; Somarathna M; Manamperi A; Escalante AA; Gunasekera AM; Udagama PV
    Vaccine; 2011 Oct; 29(43):7491-504. PubMed ID: 21784116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low genetic polymorphism of merozoite surface proteins 7 and 10 in Colombian Plasmodium vivax isolates.
    Garzón-Ospina D; Romero-Murillo L; Tobón LF; Patarroyo MA
    Infect Genet Evol; 2011 Mar; 11(2):528-31. PubMed ID: 21182986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic diversity in the transmission-blocking vaccine candidate Plasmodium vivax gametocyte protein Pvs230 from the China-Myanmar border area and central Myanmar.
    Zhao X; Hu Y; Zhao Y; Wang L; Wu Z; Soe MT; Kyaw MP; Cui L; Zhu X; Cao Y
    Parasit Vectors; 2022 Oct; 15(1):371. PubMed ID: 36253843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic diversity of transmission-blocking vaccine candidates Pvs25 and Pvs28 in Plasmodium vivax isolates from Yunnan Province, China.
    Feng H; Zheng L; Zhu X; Wang G; Pan Y; Li Y; Yang Y; Lin Y; Cui L; Cao Y
    Parasit Vectors; 2011 Nov; 4():224. PubMed ID: 22117620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Transmission-blocking vaccine candidate of Plasmodium vivax Pvs25 is highly conservative among Chinese isolates].
    Zheng L; Xu WM; Liu YJ; Yang YM; Cao YM
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2004 Feb; 22(1):16-9. PubMed ID: 15283259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic diversity of Plasmodium vivax Duffy Binding Protein II (PvDBPII) under unstable transmission and low intensity malaria in Sri Lanka.
    Premaratne PH; Aravinda BR; Escalante AA; Udagama PV
    Infect Genet Evol; 2011 Aug; 11(6):1327-39. PubMed ID: 21554998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced polymorphism of Plasmodium vivax early transcribed membrane protein (PvETRAMP) 11.2.
    Perrotti E; L'Episcopia M; Menegon M; Soares IS; Rosas-Aguirre A; Speybroeck N; LLanos-Cuentas A; Menard D; Ferreira MU; Severini C
    Parasit Vectors; 2023 Jul; 16(1):238. PubMed ID: 37461081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequence polymorphism in two novel Plasmodium vivax ookinete surface proteins, Pvs25 and Pvs28, that are malaria transmission-blocking vaccine candidates.
    Tsuboi T; Kaslow DC; Gozar MM; Tachibana M; Cao YM; Torii M
    Mol Med; 1998 Dec; 4(12):772-82. PubMed ID: 9990863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.